Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Organovo (ONVO) -- Ignore unavailable to you. Want to Upgrade?

To: Glenn Petersen who wrote (9)	10/10/2012 5:39:24 PM
From: caly	Read Replies (1) \| Respond to of 171

Thanks for the article. This technology just boggles my mind, and I think I'll always hold at least a small position in this stock until we see how it pans out.

To: Glenn Petersen who wrote (9)	2/16/2013 2:14:25 AM
From: Doren	Respond to of 171

> But after seeing opportunity to cash in on the market for human tissue, the company changed its business model to making tissues for drug companies for medical research and therapeutic applications instead. Fascinating and unique strategy. The other thing I think will be interesting: When they get to the point of printing vascular systems etc inside other tissues, they will obviously have proprietary knowledge of how cells differentiate themselves. If they get that far. Eventually they will have 3d models of tissues and eventually organs, they'll be able to size each perfectly. One model infinite number of prints.